Methylenedioxybutylamphetamine

Pharmaceutical compound From Wikipedia, the free encyclopedia

MDBU, also known as 3,4-methylenedioxy-N-butylamphetamine or as N-butyl-MDA, is a lesser-known drug.[1][2] It is the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA).[1][2]

Other namesMDBU; 3,4-Methylenedioxy-N-butylamphetamine; N-Butyl-MDA
ATC code
  • None
Quick facts Clinical data, Other names ...
MDBU
Clinical data
Other namesMDBU; 3,4-Methylenedioxy-N-butylamphetamine; N-Butyl-MDA
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • N-[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl]butan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H21NO2
Molar mass235.327 g·mol−1
3D model (JSmol)
  • C1=C2C(=CC=C1CC(C)NCCCC)OCO2
  • InChI=1S/C14H21NO2/c1-3-4-7-15-11(2)8-12-5-6-13-14(9-12)17-10-16-13/h5-6,9,11,15H,3-4,7-8,10H2,1-2H3
  • Key:RDXVRDCQDITVDV-UHFFFAOYSA-N
Close

Use and effects

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDBU's minimum dose as 40 mg orally and its duration as unknown.[1][2] MDBU produced few to no effects at tested doses.[1]

Chemistry

Synthesis

The chemical synthesis of MDBU has been described.[1]

See also

References

Related Articles

Wikiwand AI